Global Companion Diagnostic (CD) Market is Expected to Reach $3.5

Billion by 2020

Published Date: 03 May 2014

107 Pages

Report

Published Date : 10 June 2014

Table of Content

1. Introduction

2. Executive Summary

3. Global 3D Technology Market Overview

4. Global 3D Technology Market by Products

5. Global 3D Technology Market by Applications

6. Global 3D Technology Market by Geography

7. Company Profiles

In troduct ion

Scope of the Report Key BenefitsKey Audiences

Descr ipt ion

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic

responses of patients for a specific treatment. Companion diagnostics market is still nascent,

and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013,

growing at a CAGR of 20% during 2014 to 2020.

The global companion diagnostic market is segmented based on indication, technology and

geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the

fastest growing region. The key drivers for this market are the increase in the discovery of

biomarkers and co-development of drug and corresponding diagnostic.

However, cost associated with developing drugs could impede the growth of this market.

Opportunities for this market lie in developing companion diagnostics for various central

nervous system conditions and hereditary conditions.

Assessments are made according to the current business scenario and the future market trends

are forecast for the period 2013-2020, with the base figures of the year 2013

The analysis gives a wider view of the global market including its market trends, market structure,

limiting factors and opportunities for the market

Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the

competitive sketch of the market, which would guide the market players to develop strategies

accordingly

The value chain analysis provides a systematic study on the key intermediaries involved, which

would in turn help the stakeholders in the market to make appropriate strategies

The advantages of the market are analyzed to help the stakeholders identify the opportunistic

areas in a comprehensive manner

KEY BENEFITS

Companion Diagnostic Technologies Market Analysis

Companion Diagnostics Indication Market Analysis

Companion diagnostics is segmented on the basis of its use for indications such as oncology,

cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology

is the highest revenue generating segment, as majority of the companion diagnostics have been

developed for detection of various cancer biomarkers.

Companion Diagnostics Technology Market Analysis

Companion diagnostics technology market is segmented into Immunohistochemistry and Molecular

diagnostics. Molecular diagnostics would be the fastest growing and highest revenue generator,

mainly due to the use of techniques such as real time PCR, In Situ Hybridization and next

generation sequencing. Other factors contributing to the growth is technological advancements in

molecular diagnostics, which has resulted in increased accuracy and precision and also reduced

cost of testing using these methods.

Companion Diagnostics Geography Market Analysis

Companion Diagnostics market has been segmented geographically into North America, Europe,

Asia Pacific and LAMEA. North America has the major market share of 43.97% followed by Europe,

which accounted for about 38% of the overall CD market in 2013. North America and Europe

together accounted for over 82% in the global CD market in 2013 and they would continue to be the

major markets through 2020.

Companion Diagnostic Technologies Market Competitive Analysis & High Level Analysis Competitive Analysis

A study of some of the key players has showed that majority of the companies in this market are

focusing on collaborations with drug companies. Companion diagnostics is a emerging market and

companies are collaborating with drug companies to develop companion diagnostics for their

pipeline drugs, which are in developing phase. Approvals for companion diagnostics are the second

most popular strategy. Companies profiled in this report include Dako (Agilent Technologies),

Qiagen, Roche, Abbott Laboratories, Inc., Ventana Medical Systems, bioMerieux, Myriad Genetics,

Inc., Resonance Health Ltd., Leica Microsystems, and Life Technologies.

High Level Analysis

The report is focusing on the trends in technology and diagnosis of various indications, which are

driving the growth of the companion diagnostics market. Analysis of the market based on porters

five force model shows that the bargaining power of the suppliers is high as the products produced

are highly differentiated. The threat of new entrants is low as significant research and development

is required for developing diagnostic tests. Apart from the R&D requirements, the investment

required is also high. These factors make it difficult for new companies to enter the market. The

threat of substitutes is low in this market as companion diagnostics are developed for specific

biomarkers and the products are highly differentiated. Competition in this market is moderate as the

market is still emerging and there are a few companies in the market. Government regulations are

favoring use of companion diagnostics for determining a particular treatment.

1. Introduction

2. Executive Summary

3. Market Overview

4. Global Companion Diagnostic Market by Indications

5. Global Companion Diagnostic Market by Technology

6. Global Companion Diagnostic Market by Geography

7. Company Profiles

Table of Contents

Global Companion Diagnostic Technologies Market

Overview

Value

Chain

AnalysisCompanion Diagnostic

Technologies Market

OverviewGovernment

Regulations

Market

Definition and

Scope

Companion

Diagnostics

for Metabolic

Diseases

Companion

diagnostics as

a new trend in

personalized

medicine

Novel trends

&

technologies

in companion

diagnostics

assay

development

Porter’s five

forces

analysis

Key Findings

Your feedback is important to us

What would you like to know more about this Study ?

Global Industry Analysis

Market Size

Market Share

Market Trends

Opportunities and Forecast

Please inform us on : http://www.alliedmarketresearch.com/contact-us

Market Dynamics

Key Market Drivers

Market Restraints

High Cost in

research and

development of

drugs

Market Dynamics

Increase in the

Discovery of

Biomarkers as

drug targets.

Technological

advancements

Increasing

cases of

adverse drug

reactions(ADR)

Increased

popularity of

Personalized

medicine

Economic and

scientific

obstacles

Low price of competing

technologies

Companion Diagnostic Market By Indications

Companion

Diagnostic

Market

By

Indications

Oncology

Others

Inflammation and Auto-immune diseases

Companion diagnostics in cardiovascular diseases

Companion diagnostics in CNS disorders

Companion diagnostics tests in virology diseases

Others

Companion Diagnostic

Market

By

Technology

Immunohistochemistry

Molecular Diagnostics

Others

Global Companion Diagnostic Market By Technology

Top Market Players of Companion Diagnostic Market

Qiagen

Dako (Agilent Technologies)

Roche

Abbott Laboratories, Inc.

BioMerieux

Ventana Medical Systems

Myriad Genetics, Inc.

Resonance Health Ltd

Leica Microsystems

Life Technologies

Your feedback is important to us

What would you like to know more about this Study ?

Global Industry Analysis

Market Size

Market Share

Market Trends

Opportunities and Forecast

Please inform us on : http://www.alliedmarketresearch.com/contact-us

http://www.alliedmarketresearch.

com/

companion-diagnostic-

technologies-market